Loading...
Medicaid’s expenditures for newer pharmacotherapies for adults with disabilities
Shireman, Theresa I. Hall, Jean P. Rigler, Sally K. Moore, Janice M.
Shireman, Theresa I.
Hall, Jean P.
Rigler, Sally K.
Moore, Janice M.
Citations
Altmetric:
Abstract
Medicaid's drug expenditures have grown at double-digit inflation rates since 2000. These prescription drug costs are important contributors to increasing health care costs for disabled persons. In spite of this knowledge, little has been reported about specific patterns of medication use among disabled enrollees. We analyzed Kansas Medicaid data to describe trend in medication use patterns across 3 years among disabled beneficiaries. The marked shifts toward newer medications and disproportionate contributions of newer, more expensive medications to overall prescription costs for antipsychotics, antidepressants, anticonvulsants, antiulcer medications, anti-inflammatory agents, and opioids have implications for both policy and practice.
Description
Date
2007
Journal Title
Journal ISSN
Volume Title
Publisher
Health Care Financing Review
Research Projects
Organizational Units
Journal Issue
Keywords
Medicaid, Adults With Disabilities, Expenditures
Citation
Shireman, T.I., Hall, Jean, P., Rigler, S.K., & Moore, J.M. (2007). Medicaid’s expenditures for newer pharmacotherapies for adults with disabilities. Health Care Financing Review, 28(4), 31-41.